Noteworthy News

[Angrboda]

The Food and Drug Administration’s (FDA) Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive, and Urologic Drugs Advisory Committee voted 17 to 0, with no abstentions, that the benefits of making Opill®, a progestin-only daily oral birth control pill, available for over-the-counter (OTC) use outweighs the risks.

https://www.empr.com/home/news/fda-panel...SubId=&NID=

The downside is that if it is available over-the-counter, then insurance won't cover it.